Randomized Trial of Ivabradine in Patients With Hyperadrenergic

$ 5.50

5
(537)
In stock
Description

Cardiovascular autonomic dysfunction in post-COVID-19 syndrome: a

Baseline Demographics and Characteristics Randomized to Placebo

Researchers Discover Existing Drug That May Treat COVID-19

Ivabradine Knocks Down Heart Rate, Symptoms in POTS

Post-acute sequelae of SARS-CoV-2 syndrome presenting as postural

Noteworthy sequelae after COVID-19 pneumonia in a patient with

Journal of the American College of Cardiology: Vol 77, No 7

PDF) Ivabradine in Postural Orthostatic Tachycardia Syndrome: A

Perspective Chapter: Cardiovascular Post-Acute COVID-19 Syndrome